AI for Drug Discovery

Using artificial intelligence to help accelerate drug discovery, screening, development, and related pharmaceutical research.

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

BioMAP raises $100 million Series A for AI-driven drug discovery platform

News Commentary | August 06, 2021

The round was led by GGV Capital, and the Chinese biotech startup plans to use the funds to invest in further advancing its biocomputing engine and talent pool. The company leverages AI and multiomics data to develop therapeutics and diagnostics in oncology, autoimmune, and fibrotic diseases. The ... Not part of subscription

The Lux Research 2022 Foresight Report

Research Report | November 24, 2021

Great innovations occur when technologies connect to address a critical question or market need. Sustainability is that question, and connected computational tools promise to meet that need. More and more devices are being computationally connected to create increasingly novel combinations of data, ... Not part of subscription

Last-Mile Delivery

Tech Hub | February 17, 2022

Technologies and business models to deliver parcels to their final destination. Not part of subscription